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Extensive medical, public health, and social science research have focused on cataloguing maleefemale
differences in human health. Unfortunately, much of this research unscientifically and unquestionably
attributes these differences to biological causes e as exemplified in the Institute of Medicine’s conclusion
that “every cell has a sex.” In this manuscript we theorize the entanglement of sex and gender in human
health research and articulate good practice guidelines for assessing the role of biological processes e
along with social and biosocial processes e in the production of non-reproductive health differences
between and among men and women. There are two basic tenets underlying this project. The first is that
sex itself is not a biological mechanism and the second is that “sex” and “gender” are entangled, and
analyses should proceed by assuming that measures of sex are not pristine, but include effects of gender.
Building from these tenets e and using cardiovascular disease as a consistent example e we articulate
a process that scientists and researchers can use to seriously and systematically assess the role of biology
and social environment in the production of health among men and women. We hope that this inter-
vention will be one further step toward understanding the complexity and nuance of health outcomes,
and that this increased knowledge can be used to improve human health.
 2011 Elsevier Ltd. All rights reserved.Introduction
Social science and health research ubiquitously treat sex as
a dichotomized independent variable. The United States Institute of
Medicine (IOM) Committee on Understanding the Biology of Sex
and Gender Differences drew an ‘overarching conclusion’ that “Sex
. should be considered when designing and analyzing studies in
all areas and at all levels of biomedical and health-related research.
.” (xix) and that “every cell has a sex” ((Wizemann & Pardue,
2001), p.4; see also pp.28e44). Indeed, the IOM not only reified
sex as a master independent variable, but also focused its own
committee work on “sex-based differences, versus similarities, as
.more likely to. lead to greater understanding of the significance
of sex in human biology and health” (2). The IOM study did
acknowledge that social and cultural factors could contribute to
observed male-female differences in anatomy and physiology (see
especially pp.18e19). Generally, though, the committee’s analysis
departed from its official openness to such interactive models, andK.W. Springer).
All rights reserved.from its designation of “gender” as a continuum (p.17). Instead, as
two dissenting committee members noted, the committee’s overall
approach suggests a “predominance of physiology, with a subse-
quent fine-tuning by environment” (p.18), and moreover, as we
argue below, such an approach incorrectly implies that scientists
can completely “control” for gender to identify the pure substrate of
sex biology that underlies observed male-female differences.
The IOM, drawing especially on definitions advanced by the
World Health Organization (WHO) and the style manual of the
Journal of the American Medical Association (JAMA), defines sex as
“The classification of living things, generally as male or female
according to their reproductive organs and functions assigned by
chromosomal complement” and gender as “A person’s self-
representation as male or female, or how that person is respon-
ded to by social institutions based on the individual’s gender
presentation. Gender is rooted in biology and shaped by environ-
ment and experience” ((Wizemann & Pardue, 2001) p.17). These
definitions lend a superficial sense that sex and gender are distinct
domains, even as they give causal and temporal priority to biology
(“gender is rooted in biology” but sex is presumably pristine and
emerges regardless of environment and experience).
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In this paper we build on prior research to provide an alternative
to IOM-type mandates for health research where “sex” is treated as
the main explanatory variable for proposed maleefemale health
differences in human health (Bird & Rieker, 1999; Epstein, 2007;
Fausto-Sterling, 2005). We aim to articulate a theoretical frame
and good practice guidelines for exploring the role of sex-related
biology in human health, especially as it may influence non-
reproductive differences between males and females. We are
explicitlyengagingwith sexdifference researche sowe take a frame
of maleefemale difference in much of our discussion, although we
also focus on the importance of within-sex variation. There are two
basic tenets to our argument. First, sex is not a biologicalmechanism
and its use as a proxy for other measures does little to further the
understanding of health-related research questions. Second, in the
vast majority of health research, “sex” and “gender” are entangled
and analyses should proceed by assuming that measures of sex are
not pristine, but include effects of gender. We are not arguing
against any biologically based maleefemale differences. Rather we
are arguing that the vastmajority ofmaleefemale health differences
are due to the effects of the irreducibly entangled phenomenon of
“sex/gender,” and therefore this entanglement should be theorized,
modeled, and assumed until proven otherwise.
We borrow the concept of entanglement from multiple other
fields including quantum physics and science/technology studies,
where entanglement has been used to describe inextricably inter-
woven factors (Callon & Rabeharisoa, 2003; Papp et al., 2009). For
example, according to quantum physics, no individual element can
fully describe a quantummechanical state without incorporation of
other elements, and any attempt to measure a single factor inevi-
tably perturbs the remaining system rendering the results inaccu-
rate. Of course, physicists do measure physical properties, and do
accept a certain level of inaccuracy and imprecision in their work by
doing so e just as social scientists define and measure sex and
gender in research on health outcomes. Nonetheless, we maintain
that a true and full appreciation of sex/gender in human health
cannot rely on the dichotomization of people into males and
females without attention to how sex and gender may be e and
almost always are e entangled.
The idea of sex/gender entanglement is not new and a growing
body of research demonstrates the problematic task of dis-
tinguishing between sex and gender in practice (Fausto-Sterling,
2005; Kessler, 1998; Oudshoorn, 1994). Feminist epidemiologists
and biologists, among other scientists, increasingly replace the
discrete concepts of “sex” and “gender” with more complex
formulations, such as Nancy Krieger’s notions of “biologic expres-
sions of gender” and “gendered expressions of biology” ((Krieger,
2003), p. 653). As Kaiser, Haller, Schmitz, and Nitsch (2009)
recently observed, “sex is not a pure bodily and material fact, but
is deeply interwoven with social and cultural constructions of
gender” ((Kaiser et al., 2009), p.50). Fausto-Sterling (2005) has
shown in the case of bone development and change, and Jordan-
Young and Rumiati (forthcoming) have argued in the case of
brain structure and function, that gendered life experiences have
material effects on the body. These effects show up, in turn, as
biologically based “sex differences.” Indeed, the social structure of
gender even creates biological differences for boys and girls starting
in the womb (e.g. birth weight) e as evidenced by lower levels of
prenatal care for female fetuses in countries with a preference for
boys (Al-Akour, 2008).
While the causal link between “sex” and “gender” is often
thought to flow automatically from biological to social difference,
recent research has forcefully demonstrated that the influence
often operates in the other direction. A strong example can befound in social neuroendocrinology where research has confirmed
that mood states, social interactions, and status differentials affect
neuroendocrine production and function (Booth, Granger, Mazur, &
Kivlighan, 2006; Haneishi et al., 2007; Sapolsky,1997; van Anders &
Watson, 2006). One obvious conclusion is that sex-linked outcomes
related to neuroendocrine function must be conceived as flowing,
at least in part, from social variables.
The potential implications of recognizing “sex endocrinology” as
a biosocial complex are profound. Consider the relationship of
neuroendocrine factors to risks for cardiovascular disease (CVD),
whichwewill continue to use as an example throughout because of
its epidemiological importance as a primary cause of death and
because of the historical importance of CVD research originally
ignoring women and then reacting by automatically focusing on
male-female differences in sex-linked biology (Epstein, 2007;
Mosca et al., 2004).
A multidisciplinary team working on psychosocial factors in
CVD has noted, for example, that “psychosocial stress reliably
induces ovarian dysfunction, hypercortisolemia, and excessive
adrenergic activation in pre-menopausal females, leading to
accelerated atherosclerosis” (Rozanski, Blumenthal, & Kaplan,1999:
p.2192). These results of psychosocial stress constitute variables
generally characterized as aspects of “sex biology.” However, since
psychosocial stress is itself the result of processes that are
profoundly gendered (e.g., uneven family obligations, gender-
specific forms of harassment or discrimination, and greater levels
of poverty and wage insecurity), these “biological” factors are
already inextricably bound up with the social world of gender
(Rozanski et al., 1999). Despite some progress, we still know rela-
tively little about specific social-biological pathways throughwhich
gendered arrangements become embodied as within- or between-
sex differences. We therefore propose that the general dictum
should be that sex and gender are entangled, rather than the
opposite dictum as set forth by the IOM.
The difficulty in identifying the true directionality of the
“causal” links leads us to follow Kaiser et al. (2009), and use the
term sex/gender “to highlight this socio-biological intertwinement
whenever possible” ((Kaiser et al., 2009), p.50). This view of sex/
gender fits very well with the contemporary focus on intersectional
approaches to health e whereby aspects of social status (e.g.,
gender, race, socioeconomic status, and sexuality) are understood
to affect health outcomes in complex, multiplicative ways that can
never properly be captured by attempts to parcel out the individual
contributions of single social domains (Hankivsky & Christoffersen,
2008; Jackson & Williams, 2006).
We approach sex/gender in this intersectional light and
conceptualize sex/gender as a domain of complex phenomena that
are simultaneously biological and social, rather than a domain in
which the social and biological “overlap.” We use the term gender
(read: gender-not-sex) to draw attention to specifically social and
structural factors, such as patterns in the distribution of family
responsibilities, formal and informal sanctions for gender non-
conforming behavior, and so on (For recent, in-depth analyses
that support the claim that these patterns cannot be attributed to
“original” differences between males and females, see (Fine, 2010;
Jordan-Young, 2010; Jordan-Young & Rumiati, forthcoming)). We
avoid the use of the term sex (read: “sex-not-gender”) as a stand-
alone indicator of biology, or as a broad reference to males and
females (as in “sex differences”) because it is rarely specific enough
to guide particular investigations, and because it is too easily
confused with the more accurate composite phenomenon of sex/
gender that we use here.
Further, the direction of influence should not be assumed to flow
from an idealized version of “pure” biology outward to the behav-
ioral and social world. Consider, for example, glucose metabolism,
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lismhavebeen reported (Basu et al., 2006; Peterson et al., 2007), and
cellular level mechanisms related to glucoseeinsulin interactions
have been hypothesized to explain this difference (Basu et al., 2006).
Yet a recent experimental study of response to oral glucose “chal-
lenge” found that the male-female difference, comparable in size in
this study to other reports, could be entirely explained by difference
in skeletal muscle mass between men and women (Rattarasarn,
Leelawattana, & Soonthornpun, 2010). Given the extensive data on
social influences on the male-female difference in muscle mass (for
instance, via differential nutrition, aesthetic norms, occupation, and
use of outdoor spaces for exercise), themetabolic differences seen at
the cellular level betweenmales and females could beunderstood as
bearing the traces of their gendered lives (Bentley et al., 1999;
Courtenay, 2000; Richardson & Mitchell, 2010).
In a case such as this, sex/gender is a preferable notation to “sex”
alone, although the exact qualities that sex/gender represent may
not be fully specified. Unmeasured aspects of gender will always be
present and usually we will be unaware of the specific ways in
which gendering of activities, as through nutrition and psychology,
affects cellular level processes.
Good practice guidelines for examining male-female human
health differences
We build on the theoretical frame of sex/gender entanglement
to present an encapsulation of good practice guidelines forRESEARCH PLAN DEVELOPMENT 
A PRIORI COMPARISON PLAN
INTERPRETATION AND PRESENTATION OF R
1. Present within group and between group differ
2. Explain effect size: substantive vs. significant 
3. Report post-hoc tests and adjust significance le
4. Describe social/biosocial attenuation and the p
5. Describe similarities and differences for biolog
6. Thoroughly report limitations of the study and
1. Fully define outcome and independent measure
2. Identify plausible biological mechanism(s) exp
3. Directly test the biological mechanism(s) – if a
4. Develop, operationalize, and test alternative hy
pathways.
5. Incorporate and test the biological and social/b
1. Include appropriate control groups for ALL hy
accurately test for differences
2. Include sufficient measures for confounders an
3. Attend to issues of statistical significance and s
4. Conduct sensitivity analyses
Fig. 1. Good practice guidelines for researesearching male-female health differences (Fig. 1). This encapsu-
lation is critical because these good research practices are often
ignored in sex/gender and health research, which hampers the
ability of research to provide fruitful insights into health inequal-
ities and disparities. These guidelines are organized into three
sequential sections (research plan development; a priori compar-
ison plan; and interpretation and presentation of results), but as
with all research, looping back through the sections is inevitable
and desirable.
Research plan development
Because we posit that sex and gender are entangled, the first
step is to assess whether or not biological male-female difference
research is both warranted and possible. If yes, the next step is to
a priori develop and articulate specific, testable hypotheses, with
precise well-definedmeasures observable in bothmen andwomen,
and to articulate plausible biological/biosocial mechanisms to
explain the biological contribution to male-female health differ-
ences. (Biological mechanism is not meant to suggest that biology
can be separated from the social environment, but rather to refer to
specific mechanisms that can be described in molecular or
biochemical terms.)
Fully define outcome and independent measures a priori
An accurate understanding of the biological contributions of










potheses that include social and biosocial 
iosocial mechanisms together.
potheses (biological, social, biosocial) and 
d covariates
ample size
rching sex/gender in human health.
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example of CVD, we see that the rubric “cardiovascular disease”
itself may be too broad for elucidating observed male-female
differences in rates. The International Classification of Diseases
(ICD- 9) uses the codes 350 to 459 to classify circulatory system
diseases. “Ischemic heart disease” uses more than 20 different
codes. The 16th edition of Harrison’s Manual of Medicine includes
13 sub-sections on CVD (Kasper, Braunwald, Fauci, Hauser, Longo, &
Jameson, 2005). True biological maleefemale differences in CVD
would be expected to vary in important ways depending on the
specific aspect of CVD under investigation.
CVD studies may also include a wide range of clinical signs and
symptoms like chest or back pain (Berg, Bjorck, Dudas, Lappas, &
Rosengren, 2009; Hendrix, Mayhan, Lackland, & Egan, 2005),
serum progesterone level (Nilsson, Fransson, & Brismar, 2009), or
a psychosocial risk factor like depression (Rozanski et al., 1999). One
complication in defining measures is that physicians may differ-
ently diagnose and treat the same presentation of symptoms
depending on whether the patient is male or female (Enriquez,
Pratap, Zbilut, Calvin, & Volgman, 2008).
In addition, studies of the “same” outcome can produce
dramatically different results depending on the definitions and
measures used to operationalize the outcome. For example,
research onmale-female differences in the CVD-related outcome of
metabolic syndrome shows great variation in the size, shape, and
even the presence of male-female differences depending on the
definition of the outcome used in the study. As articulated by
Regitz-Zagroskek et al. (2006): “Classification according to WHO
criteria generally led to a 50% higher estimation of prevalence
compared with the EGIR (European Group for the Study of Insulin
Resistance) criteria in men. This can mostly be explained by the
different cut-off value for central obesity used in the WHO defini-
tion. For women, the difference was smaller.” (p.137).
Sex/gender differences in a specifically defined outcome may be
partially explained by other factors (Naqvi, Naqvi, & Merz, 2005;
Rozanski et al., 1999; Suarez, 2006). Duprez et al. (2009) found
significant male-female differences in arterial elasticity e an indi-
cator of progression to cardiovascular morbidity and mortality e
that were completely accounted for by height differences between
men and women. Importantly, the broad variability in height
within both sexes means that using sex as a proxy for arterial
elasticity results in, at best, unnecessary loss of information and, at
worst, gross misclassification errors leading to erroneous results.
Identify plausible biological mechanism(s) explaining maleefemale
difference
Studies should be designed to explicate plausible biological
mechanisms and “sex,” as such, is not a mechanism. Putative male-
female difference must be tied to plausible biological mechanisms
and operationalized into measurable variables. A thorough, critical
investigation of the literaturewill assist in understanding biological
mechanisms and how they can be operationalized before
proceeding with hypothesis development. How the mechanism(s)
would be different in men and women e on average e must be
articulated. For example, male-female differences in mortality have
been linked to male-female variations in metabolic syndrome and
diabetes, a CVD risk factor. As explained by Regitz-Zagrosek,
Lehmkuhl, and Weickert (2006): “Lipid accumulation patterns
differ between women and men. Pre-menopausal women more
frequently develop peripheral obesity with subcutaneous fat
accumulation, whereas men and post-menopausal women are
more prone to central or android obesity. In particular, android
obesity is associated with increased cardiovascular mortality and
the development of type 2 diabetes” (p.136). Here the proposed
biological mechanism for male-female difference is not for allfemales and males e but for pre-menopausal women compared to
men (and post-menopausal women), underscoring the complexity
(and generally unacknowledged variability) of the categories
“male” and “female.” (It is also possible that differential deposition
of fat is socially created, as discussed below.)
Directly test the biological mechanism(s) e if at all possible
Identifying a maleefemale difference in an outcome does not
tell us anything about the possible mechanisms (biological or
social) that may produce this difference. Therefore, using sex as
a variable is an inadequate proxy for testing a proposed biological
mechanism. For example, if the proposed biological pathway for
CVDmortality is central or android obesity, then it is more useful to
directly measure men’s and women’s obesity, rather than simply
including a “sex” variable and then hypothesizing that the effect is
due to a difference (on average) in the location of men’s and
women’s fat stores. Even multilevel dichotomous measures, like
male, pre-menopausal female, and post-menopausal female, do not
measure a mechanism (Regitz-Zagrosek et al., 2006). Sex encom-
passesmany other qualities besides themechanism in question and
will not exhaustively describe the mechanism.
Clearly, theory oftenwill outstrip the ability to measure, and not
having access to sufficiently large cohorts and/or sufficient funds to
take biological measurements may make it unfeasible to rigorously
follow our proposed good practice guidelines (Giannattasio et al.,
2007; Regitz-Zagrosek et al., 2006). In such cases, authors must
be conservative in interpreting their findings and should avoid
overbroad generalization of their findings. Studies in which sex has
been used as a proxy for more specific measures can only be
considered suggestive, and where possible, should be avoided.
Develop, operationalize, and test alternative hypotheses that include
social and biosocial pathways
Most models in health research are incomplete and many
relevant factors are omitted for practical reasons of measurement
and feasibility. One way to address this problem in sex/gender
health research is to develop alternative hypotheses that always
include social and biosocial pathways. It is important to consider
prior studies to best conceptualize and model these alternative
hypotheses. For example, if prior research indicates that the size or
direction of male-female difference varies over time, place, or
sample characteristics (e.g., by ethnicity, age, occupation, height,
menopause, or country of residence) this provides strong evidence
of social and/or biosocial effects and offers insights into key vari-
ables for alternative hypotheses (Macintyre, Hunt, & Sweeting,
1996). Modeling with relevant social/behavior measures may
show that the presumed biological underpinnings of the observed
male-female differences in health are spurious.
Indeed, based on a plethora of evidence social causes should be
assumed and a preponderance of evidence required before arguing
for a primarily biological, non-social mechanism. Consider the
relationship between fat intake, adiposity, and CVD (Mente, de
Koning, Shannon, & Anand, 2009; Regitz-Zagrosek et al., 2006). At
least two concurrent secular trends are of importance: 1) relatively
high levels of unhealthy dietary fats; and 2) higher male CVD rates
compared to pre-menopausal women (although the gap is nar-
rowing) (Towfighi, Zheng, & Ovbiagele, 2009). Possible biological
pathways used to explain the male-female difference focus on how
men and women process fat and cholesterol in ways that differ-
entially affect CVD (Clifton & Nestel, 1992; Regitz-Zagrosek et al.,
2006). Other research suggests that increases in boys’ testosterone
levels activate hepatic lipase activity, in turn, leading to a decrease
in HDL cholesterol levels for boys e but not girls. Clifton and
Nestel’s (1992) “crossover, randomized, double-blind dietary trial”
tested for male-female differences in plasma lipid responses
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evidence for differential processing formales and females. But here,
too, alternative hypotheses to explain the observed male-female
difference using social pathways are possible. Normative concep-
tions of men as strong and hearty, compared to women as slender
and delicate, shape the types and quantities of food eaten. Specif-
ically, in some cultural contexts, men are more likely to eat red
meat and women are more likely to eat fruits and vegetables
(Prattala et al., 2007). Sometimes the richest (and most unhealthy)
meat is reserved for males when there are variations in quality and/
or insufficient quantity for the whole family (Holm & Mohl, 2000).
Gendered social processes could be an alternative plausible
mechanism linking the higher male rates of CVD with increased
intake of saturated fat, or an alternative hypothesis could be based
on the confluence of the social and biological mechanisms: higher
male intake of fattier meats and dairy products (social processes)
and differential male processing is more harmful for men (biolog-
ical process).
Incorporate and test biological and social/biosocial mechanisms
together
Inclusion of social and biosocial mechanisms alongside the
originally proposed biological mechanism will improve design
becausemediation and/or spurious associations are only observable
when multiple mechanisms are considered. Alternative mecha-
nisms will help establish whether the biological mechanism is: 1)
spurious and can be accounted for by social/structural factors, 2)
actually a biosocialmechanismwhich varies in type, scope, level etc.
by social/environmental causes, and/or 3) a substantively mean-
ingful size relative to other social/structural paths. For example,
biological contributions fromcomorbid conditions like diabetes and
hypertension cannot completely account for women’s dispropor-
tionately greater adverse outcomes following an acute myocardial
infarction (MI) (Naqvi et al., 2005). However, womenwith CVD have
higher rates of depression, which, in turn, is both socially mediated
and a key risk factor for poor cardiovascular outcomes (Naqvi et al.,
2005; Whooley et al., 2008). The observed differential recovery
from acute MI and the relatively unexplored role of depression in
the causal pathway illustrates the importance of incorporating
social/biosocial mechanismswithin studies exploring the biological
contribution to male-female differences in CVD outcomes.
A priori comparison plan
Comparison groups and statistical tests of effects should be
developed based on previous empirical evidence and theory prior
to proceeding with the research. Carefully planning for compari-
sons can help avoid the temptation to make atheoretical compar-
isons simply because the design includes a “sex variable” and
a range of interesting outcomes. Such unplanned comparisons
almost always yield false positives and can be particularly
damaging given the bias towards interpreting male-female differ-
ences as ‘probably true’ and ‘probably biological’ (Jordan-Young,
2010; Kaiser et al., 2009).
Include appropriate control groups for all hypotheses (biological,
social, biosocial) and accurately test for differences
Comparison groups should be strictly comparable. This is
particularly important for conducting statistical tests of similarity/
difference e without this strict comparability the substantive
meaning of tests of statistical difference is unclear. Conclusions
based on ad hoc comparison of statistical tests conducted within
groups of men and women are not supportable. Phrases like “more
statistically significant” in one group versus another have little
practical meaning since such differences could easily be the resultof differences in sample sizes, bias in assembling the population,
or inadequacy of the measures used. A significant finding in one
group and a non-significant finding in the other group is likewise
not evidence of a male-female difference. To compare groups it is
necessary to test for the significance of a statistical interaction
and/or to formally test whether the effect for one group is
significantly different from the effect for another group (Aiken &
West, 1991).
Include sufficient measures for confounders and covariates
Statistical tests of incomplete models have limited meaning.
Models must include confounders and covariates, as well as test for
plausible mediation and interactions to avoid spurious findings. For
example, Kanaya, Grady, and Barrett-Connor (2002) conducted
a meta-analysis to assess the claim that diabetes is a stronger
independent risk factor for coronary heart disease mortality in men
than inwomen. The authors found nomale-female differences after
adjusting for other classic CVD risk factors (Kanaya et al., 2002). In
other words, a previously established risk factor (diabetes) for
male-female differences in CVDmortality was found to be incorrect
when appropriate controls were included in the model.
Attend to issues of statistical significance and sample size
Sample size issues plague many studies but research often
proceeds with relatively little attention to how sample size may
affect findings and interpretation. The effect of sample size can
operate in two directions: very large samples can produce artifac-
tual significant relationships at the p < 0.05 level (McCloskey,
1985). Very large samples, as in gene-wide array studies, GWAS,
may require a much stricter level of significance (i.e. p < 105 or
smaller) (Caporaso et al., 2009). One common and reasonable
strategy is to use Bonferroni corrections based on the baseline p-
value determined by the sample size (Rice, 1989). The Bonferroni
correction simply involves dividing the baseline significance level
(i.e. p < 0.05) by the number of comparisons, yielding the new p-
value for statistical significance.
Small sample sizes may compromise one’s ability to detect an
effect. The smaller the sample and the weaker the effect size, the
more difficult it will be to achieve sufficient power. Small samples
may also make testing interactions difficult if not impossible and
biosocial interactions are fundamental to understanding sex/
gender differences. For example, a study with 80% power to detect
a main effect will only have 29% power to detect an interaction
effect of the same magnitude (Brookes et al., 2004).
Conduct sensitivity analyses
To assess the robustness of the findings and to understand
possible variations in effects, an array of sensitivity tests, ideally
identified a priori, should be conducted. The specific tests depend
on the research question(s) but could include: a) testing different
operationalization of variables e e.g. a continuous vs. categorical
measure of BMI; b) different modeling techniques to assess viola-
tions of modeling assumptions; c) alternative treatment of outliers,
including transforming skewed variables and removing extreme
cases. Sensitivity tests should be fully reported when presenting
results e especially, if the outcome of sensitivity tests is not
consistent with the original results.
Interpretation and presentation of results
Present within group and between group differences
Exploring variation within men and within women can help
illuminate the practical/real significance of a male-female differ-
ence. If the observed magnitude of the variation within men or
within women is comparable to the male-female difference, then
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natural variation within men or women. As with our earlier
example, the difference in average heights between men and
women in the U.S. is 5 inches (5ft, 8 inches for men and 5ft, 3 inches
for women) (McDowell, Fryar, Ogden, & Flegal, 2008), but the
height difference between the 5th and 95th percent of height for
men and women in the U.S. is 10 inches and 9 inches respectively
(McDowell et al., 2008). Such intra-sex height variations can lead to
erroneous conclusions about male-female differential CVD risks.
Data show that the example of reduction in arterial elasticity as
a biological indicator of progression toward cardiovascular
morbidity and mortality discussed earlier is dependent on height,
regardless of sex/gender (Duprez et al., 2009).
Explain effect size(s): substantive vs. significant difference
Statistical significance is not substantive significance (Miller,
2005). A recent meta-analysis on sex differences in the associa-
tion between birth weight and total cholesterol (a CVD risk factor)
found evidence for a greater effect of low birth on cholesterol
amongmen vs. women, attributed to “different biological processes
for females and males” ((Lawlor et al., 2006) p.19.) But the effect
size, 0.04 mmol/l in total cholesterol per kg birth weight, was called
“unlikely to have important public health effects.” (Lawlor et al.
2006, pg 23). The substantiveness, as well as statistical signifi-
cance of findings, can illuminate the real-life importance (or lack
thereof) of any effect.
Report post-hoc tests and adjust significance level appropriately
Interesting findings may emerge after the hypothesized anal-
yses, and post hoc statistical testing of these findings is good
practice; however, such testing increases the likelihood of false
positives. Reporting that tests were post-hoc, as well as adjusting
significance level for the number of post-hoc tests assessed provides
a clear account of the procedures and helps assure that significant
findings are not statistical artifacts.
Describe social/biosocial attenuation and the purely social/biosocial
findings
The results of the biological contribution to maleefemale
differences in health can best be understood when situated in the
context of the biosocial and social mechanism results. Describing
results from all mechanisms e alternative social and biosocial
mechanisms as well as full models with all mechanisms e can help
illuminate the relative importance of different social, biological,
and biosocial effects. This presentation of the findings allows
researchers and readers to compare and theorize the potential for
complementary, competing, and interactive social, biosocial, and
biological mechanisms.
Describe similarities and differences in biological causes
Similarity may be larger than difference, and also very inter-
esting and useful. Similarity should therefore be considered with
the same level of sophistication and attention given to explaining
differences. For example, extensive research has focused on steroid
hormones as one key cause of male-female difference in CVD risk
(Ding, Song, Malik, & Liu, 2006; Perez-Lopez, Larrad-Mur, Kallen,
Chedraui, & Taylor, 2010). However, there are also important and
interesting similarities in the effects of hormones and CVD risk for
men and women. The most striking example of these male-female
similarities is the narrowing of CVD risk between men and women
post menopause (Mendelsohn & Karas, 2005). Research has iden-
tified several hormonal similarities that drive these findings
including similar increases in CVD risk for men and post-meno-
pausal women associated with endogenous ratios of estradiol to
progesterone (He et al., 2007).Thoroughly report limitations of the study and provide enough
information for replication
Full disclosure of limitations in the design, method, or analyses
of the research can help readers understand the scope and signif-
icance of the findings e as well as spur new research endeavors to
help account for these limitations. Further, replication is the heart
of science. Depending on space constraints and journal guidelines,
it may be possible to report all information necessary to reproduce
the analyses in published manuscripts. Alternatively, or in addition,
manuscripts could include a link to a website that houses all
information needed to reproduce the findings, including data and
codes.
Discussion
We have attempted to present an alternative approach to
automatic investigation of “sex differences” in human health
studies and we have taken issue with assuming that sex is an
individual-level variable that should be routinely assessed. Indeed,
we propose the IOM mandate for maleefemale difference research
be stood on its head: research should proceed with models based
on either entirely social causes or interactive biosocial causes
unless there is sound and extensive evidence for a primarily bio-
logical mechanism. We further propose that assessments of sex are
almost without exception made for individuals whose develop-
ment, including physical, physiological, and psychological, has been
profoundly affected, in ways that we at present only dimly under-
stand, by the operations of gender. Even when so seemingly bio-
logical and non-social an entity as a “cell” is assigned a sex, the
biography of the individual that the cell came from goes along for
the ride, but this is rarely acknowledged, let alone examined, in
scientific analyses.
One potentially paradoxical result of our proposal to avoid the
broad use of “sex” as a variable is that it could facilitate a more
precise investigation of which aspects of biology contribute to
male-female differences in health, and how they do so. Messing
and Mager Stellman (2006), among others, have urged epidemiol-
ogists to avoid the use of the term sex as a broad proxy for biology as
if the term conveyed a mechanism for generating maleefemale
differences (Messing & Mager Stellman, 2006).
Here we used CVD to illustrate the good practice guidelines, but
these guidelines are applicable to other outcomes, as supported by
meta-analyses of male-female genetic differences. Patsopolous
et al. (2007) found that the vast majority of highly prominent
claims of sex-related differences in GWAS were insufficiently
documented or spurious. Patsopoulos and colleagues also noted
that only a small fraction of supposedly a priori considerations for
examining male-female differences in genetic associations did, in
fact, draw upon “any kind of corroboration history” (Patsopoulos,
Tatsioni & Ionnidis 2007, 888e889). While Patsopoulos and
colleagues do not make this point, we would emphasize that the
habit of viewing male and female as the fundamental division
between people makes it all too easy to hold a priori expectations of
male-female difference even when there is no existing empirical
evidence on which to base this expectation.
A final note on the long history and politics of usingmale-female
differences in biology and health to support a wide range of polit-
ical and social restrictions on women is in order (Barker-Benfield,
1976; Ehrenreich & English, 1978; Hubbard, 1990). In the 1970s,
the women’s health movement noted a pervasive lack of compre-
hensive and unbiased knowledge about women’s bodies, and
decried the tendency for medicine to proceed as if the “normal” or
“ideal” patient is a white, middle-class, 160 pound man (Boston
Women’s Health Book Collective, 1973; Epstein, 2007; Tuana,
2006). We recognize the IOM Report as part of a contemporary
K.W. Springer et al. / Social Science & Medicine 74 (2012) 1817e1824 1823response to the ensuing call for greater attention to women’s
bodies in medical research and practice, and believe that a dedica-
tion to rectifying longstanding male biases in medicine motivates
many who currently pursue sex-difference analyses. We applaud
that goal, and indeed share it. But for all the reasons we have
documented in this essay, we are convinced that the present
approach, especially the overarching commitment to identifying
and prioritizing difference over similarity, the prioritization of
biology, the mandate to address sex as a grouping variable in
federal funded research and clinical trials, regardless of biological
evidence, and the mistaken belief that biology can be operationally
separated from the social environment will not lead to the desired
aim. An ever-growing catalogue of differences is not likely to ach-
ieve significant health gains for either men or women, andwill only
continue to distract us from the kind of focused research into
specific mechanisms that we need, by offering the rather
empty answer of “sex” to all questions we pose about the cause of
maleefemale disparities.
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